Eric Singhi/X
Nov 11, 2024, 10:19
Eric Singhi: The ever-evolving 1st line treatment landscape of metastatic EGFR+ NSCLC
Eric Singhi, Assistant Professor at The University of Texas MD Anderson Cancer Center, shared a post on X:
“Thoracic Tumor Board Tuesday during Lung Cancer Awareness Month? An easy yes!
Join Kelsey Pan and I this week as we discuss the ever-evolving 1L treatment landscape of metastatic EGFR+ NSCLC!
Date: 11/12/24
Time: 8-9 PM ET.”
More posts featuring Eric Singhi.
Dr. Eric K. Singhi is a thoracic and head and neck medical oncologist, currently serving as an Assistant Professor in the Department of General Oncology within the Division of Cancer Medicine at The University of Texas MD Anderson Cancer Center in Houston, TX.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 08:39
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58